Announcement of Resolutions of the Twelfth Meeting of the Fifth Board of Directors of Antu Biotechnology
Securities code: 603658 Securities abbreviation: Antu Biotechnology Announcement number: 2026-017
Zhengzhou Antu Bioengineering Co., Ltd.
Announcement of Resolutions of the Twelfth Meeting of the Fifth Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
All directors attended this board meeting.
No director voted against/abstained from voting on this board meeting.
All resolutions passed by the board of directors were approved.
1. Convening of board of directors meetings
The meeting notice and materials for the 12th meeting of the fifth board of directors of Zhengzhou Antu Bioengineering Co., Ltd. (hereinafter referred to as "Antu Biotech" or the "Company") were issued by email on April 18, 2026, and the meeting was held in public on April 21, 2026. The company conference room was held by a combination of on-site and communication methods. The meeting should be attended by 12 directors, and 12 directors actually participated in the voting (including directors Zhang Yaxun, Yang Zengli, Wu Xuewei, Fu Guangyu, Zhang Ruifeng, Liu Wei, and independent director Yuan Huagang attended the meeting by communication). The meeting was chaired by Mr. Miao Yongjun, chairman of the company, and the company's senior managers attended the meeting.
The convening and holding procedures of the meeting are in compliance with the relevant laws, administrative regulations, departmental rules, normative documents and the Articles of Association such as the "Company Law of the People's Republic of China" and the relevant provisions of the "Articles of Association". The resolutions formed at the meeting are legal and valid.
2. Review status of board of directors meeting
After careful deliberation by the directors present at the meeting, the following proposals were unanimously adopted by registered vote:
- Consideration and adoption of the “Proposal on the First Quarter Report of 2026”
This proposal has been reviewed and approved by the Audit Committee of the Company's Board of Directors and agreed to be submitted to the Board of Directors for review.
For details, please refer to the announcement disclosed by the company on the Shanghai Stock Exchange website (www.sse.com.cn) on the same day. Voting results: 12 votes in favor, 0 votes against, 0 abstentions.
- Considered and approved the "Proposal on Changing the Company's Financial Director"
This proposal was reviewed and approved by the Nomination Committee and Audit Committee of the Company's Board of Directors, both of which agreed to be submitted to the Board of Directors for review.
For details, please refer to the announcement disclosed by the company on the Shanghai Stock Exchange website (www.sse.com.cn) on the same day. Voting results: 12 votes in favor, 0 votes against, 0 abstentions.
Announcement is hereby made.
Board of Directors of Zhengzhou Antu Bioengineering Co., Ltd.
April 22, 2026